James R. Kasinger

James R. Kasinger

General Counsel · CRISPR Therapeutics AG

Rank #11,624 SEC EDGAR (United States) ↗ Files from United States

Details

Officer of the companyPharmaceuticals & BiotechnologyCRSPSEC CIK 0001708172

Computed from SEC EDGAR filings and closing prices — not copied from any wealth ranking. Dataset . How we calculate this.

Disclosed holdings
$5.3M
1-day change
▼ 1.24%
Positions on file
1
issuers disclosed in Forms 3/4/5 and Schedules 13D/G

Disclosed holdings over time 53 weekly points

What the 1 currently disclosed position would have been worth at each week’s closing price. A rising line means the shares got more valuable, not that this person bought more.

How the line is built

Share counts are as last reported to the SEC and held constant; only prices move.

2025-09-05$4.3M – $6.9M2026-09-04

Insider activity Oct 13, 2024 – Mar 23, 2026

James R. Kasinger is recorded in filings to the U.S. SEC via EDGAR as officer of the company, and reported 22 transactions between Oct 13, 2024 and Mar 23, 2026. The buy and sell totals below count only codes P, S.

Why the other codes are excluded

Share awards (A), shares withheld to pay tax (F), option exercises (M) and gifts (G) also appear in the table, but they are consequences of a pay package or a private transfer, not a decision to buy or sell on the open market. Counting them would turn this into a compensation ranking.

Open-market buys (code P)
None
0 purchases on file
Open-market sales (code S)
$1.62M
11 sales on file priced rows only
All reported transactions
22
every code, including awards and exercises
Pattern
Net seller in the final 12 months of the window
last 12 months of the window

Reported transactions

Price 0.00 is a real reported figure on gifts (G) and share awards (A) — not a missing number. The 22 most recent rows are grouped into 22 lines by date, company and transaction type — open a line to see every lot with its own source link.

How to read this list

Every row is one line of one Form 4 or Form 5, with the filing it came from. Where the record carries no price at all we leave the cell empty instead of guessing one.

The shares and money on a grouped line add up only the lots listed inside that line, and only when every one of them carries the figure. Where a group mixes more than one reporting currency we leave the money blank rather than convert — no source publishes the rate that conversion would need.

  1. CRISPR Therapeutics AG CRSP S Open-market sale 3,182 shares $148.9K at $46.78 SEC filing ↗
  2. CRISPR Therapeutics AG CRSP M Option exercise or conversionnot a buy/sell decisionreported at zero 6,250 shares $0 at $0.00 SEC filing ↗
  3. CRISPR Therapeutics AG CRSP S Open-market sale 3,450 shares $166.5K at $48.26 SEC filing ↗
  4. CRISPR Therapeutics AG CRSP M Option exercise or conversionnot a buy/sell decisionreported at zero 6,875 shares $0 at $0.00 SEC filing ↗
  5. CRISPR Therapeutics AG CRSP S Open-market sale 2,800 shares $147.8K at $52.80 SEC filing ↗
  6. CRISPR Therapeutics AG CRSP M Option exercise or conversionnot a buy/sell decisionreported at zero 5,500 shares $0 at $0.00 SEC filing ↗
  7. CRISPR Therapeutics AG CRSP S Open-market sale 2,112 shares $111.0K at $52.58 SEC filing ↗
  8. CRISPR Therapeutics AG CRSP M Option exercise or conversionnot a buy/sell decisionreported at zero 3,825 shares $0 at $0.00 SEC filing ↗
  9. CRISPR Therapeutics AG CRSP S Open-market sale 1,076 shares $71.7K at $66.60 SEC filing ↗
  10. CRISPR Therapeutics AG CRSP M Option exercise or conversionnot a buy/sell decisionreported at zero 2,114 shares $0 at $0.00 SEC filing ↗
  11. CRISPR Therapeutics AG CRSP S Open-market sale 3,185 shares $131.3K at $41.23 SEC filing ↗
  12. CRISPR Therapeutics AG CRSP M Option exercise or conversionnot a buy/sell decisionreported at zero 6,250 shares $0 at $0.00 SEC filing ↗
  13. CRISPR Therapeutics AG CRSP S Open-market sale 1,116 shares $48.3K at $43.32 SEC filing ↗
  14. CRISPR Therapeutics AG CRSP M Option exercise or conversionnot a buy/sell decisionreported at zero 2,250 shares $0 at $0.00 SEC filing ↗
  15. CRISPR Therapeutics AG CRSP S Open-market sale 2,850 shares $120.9K at $42.42 SEC filing ↗
  16. CRISPR Therapeutics AG CRSP M Option exercise or conversionnot a buy/sell decisionreported at zero 5,500 shares $0 at $0.00 SEC filing ↗
  17. CRISPR Therapeutics AG CRSP S Open-market sale 1,947 shares $102.8K at $52.80 SEC filing ↗
  18. CRISPR Therapeutics AG CRSP S Open-market sale 9,595 shares $516.7K at $53.85 SEC filing ↗
  19. CRISPR Therapeutics AG CRSP M Option exercise or conversionnot a buy/sell decisionreported at zero 3,825 shares $0 at $0.00 SEC filing ↗
  20. CRISPR Therapeutics AG CRSP M Option exercise or conversionnot a buy/sell decisionreported at zero 20,000 shares $0 at $0.00 SEC filing ↗
  21. CRISPR Therapeutics AG CRSP S Open-market sale 1,089 shares $50.4K at $46.28 SEC filing ↗
  22. CRISPR Therapeutics AG CRSP M Option exercise or conversionnot a buy/sell decisionreported at zero 2,113 shares $0 at $0.00 SEC filing ↗

Disclosed holdings

Shares is the amount on the form; value is that amount times the closing price shown. Rows with no closing price are left blank, so they may add up to less than the headline figure.

What is not counted here

Each row is one filing you can open. Private companies, real estate, bonds and crypto are not in SEC insider filings and are therefore not counted here.

Equity positions disclosed to the SEC, with the source filing behind each row.
Issuer Ticker Security Shares Close Value Form Reported Filing
CRISPR Therapeutics AG CRSP Common Shares 94,308 $55.79 $5.3M 4 EDGAR ↗

Other insiders at the same companies

People who also file with the SEC at a company where James R. Kasinger reports shares.

Sharing a filing does not mean they work together day to day — it means both names appear on the same issuer’s insider record.

Sources

The filings linked in the tables above are the sources for every figure on this page.

Portrait photograph: CRISPR Therapeutics AG (company-published photograph). Original file page on crisprtx.com ↗

Think a number here is wrong? Open the linked filing and compare — how to report it.

Profile record last refreshed Sep 8, 2026.